Scientists Develop Tools for Early Detection of SARS-CoV-2 Variants in Wastewater

MSU Researchers Use AI to Stay Ahead of COVID-19 and Other Diseases

Soligenix Announces Successful Protection Using a Bivalent Thermostabilized Filovirus Vaccine

Good News on Blocking a Virus Considered A Global Threat

Jeffrey Glenn Receives $69 Million to Start Antiviral Drug-Discovery Center at Stanford

Overestimating Population Immunity Contributed to US Delta Variant Surge

Georgia State Researchers Awarded More Than $6 Million to Fight Emerging Diseases with Midwest Antiviral Drug Discovery Center

Publish or Event Date
Research Institution
Georgia State University
Short Title
Georgia State Researchers Awarded More Than $6 Million to Fight Emerging Diseases with Midwest Antiviral Drug Discovery Center
Content Coordinator
Content Manager

Protein Nanoparticle Vaccine Shows Potential for Broader, Safe SARS-CoV-2 Vaccines, Biomedical Sciences Researchers Find

Media Type
Article
Publish or Event Date
Research Institution
Georgia State University
Short Title
Protein Nanoparticle Vaccine Shows Potential for Broader, Safe SARS-CoV-2 Vaccines, Biomedical Sciences Researchers Find
Content Coordinator
Content Manager

Computer Model Predicts Dominant SARS-CoV-2 Variants

UF Scripps Scientists to Receive $15 Million to Help Fight Current and Future Pandemics

Media Type
Article
Publish or Event Date
Research Institution
University of Florida Health
Short Title
UF Scripps Scientists to Receive $15 Million to Help Fight Current and Future Pandemics
Content Coordinator
Content Manager